A r t i c l e s T cells and macrophages depleted of Trex1 by RNA-mediated interference, cytosolic HIV DNA accumulates and triggers interferon through the STING-kinase TBK1-IRF3 pathway 11 . Those findings and other studies 12 suggest that cells rely on negative regulatory molecules such as Trex1 to keep cytosolic DNA-sensing pathways in check.
Trex1 deficiency has been linked to the pathogenesis of autoimmunity. TREX1 mutations in humans are associated with a spectrum of autoimmune and inflammatory phenotypes, including Aicardi-Goutières syndrome (AGS; an inflammatory brain disease that mimics the symptoms of congenital viral infection 13, 14 ), systemic lupus erythematosus (SLE), familial chilbain lupus, and retinal vasculopathy with cerebral leukodystrophy [15] [16] [17] . TREX1 mutations have been found in up to 2% of patients with SLE, with an extremely high odds ratio (of 25) 18 ; thus, such mutations represent one of the highest disease risks recorded for a single susceptibility gene in complex polygenic SLE 14 . Studies of Trex1 −/− mice have shown that Trex1 −/− cells accumulate cytosolic single-stranded DNA that might be derived from DNA repair in the nucleus or from endogenous retroelements 19, 20 . Genetic evidence has demonstrated that the STING-mediated DNAsensing pathway is essential for the pathogenesis of autoimmune disease in Trex1 −/− mice 12 . The initiation of interferon expression is detected in only a subset of nonhematopoietic cells in Trex1 −/− mice, which raises the question of what happens to the majority of other cells that also lack Trex1 function. We also wondered whether Trex1 inhibits interferon responses to other viruses beyond HIV and/or if the mere loss of Trex1 function in a cell would elicit innate immune responses and establish an antiviral state.
In this study, we found that Trex1-deficient and Trex1-mutant cells had broad antiviral activity against many RNA viruses. The antiviral activity was provided by higher expression of ISGs in cells that lacked Trex1 function and was mediated through an interferonindependent signaling pathway that involved STING, TBK1, IRF3 and IRF7. We also found that Trex1 regulated lysosomal biogenesis through the transcription factor TFEB and the regulator mTORC1 and provide evidence that dysregulation of lysosomes elicits innate immune responses.
RESULTS

Impaired VSV replication in Trex1-deficient cells
To investigate whether Trex1 is involved in the interferon response to RNA viruses, we infected wild-type and Trex1 −/− MEFs with the Indiana strain of vesicular stomatitis virus (VSV; a negativestranded RNA virus), with VSV glycoprotein (G protein)-pseudotyped HIV 11 or treated them with mock infection, then measured mRNA encoding interferon-β (IFN-β; Ifnb mRNA) 24 h after infection. As reported before 11 , mock-infected wild-type and Trex1 −/− cells did not have detectable expression of Ifnb mRNA, and infection with HIV stimulated the expression of Ifnb mRNA only in Trex1 −/− cells, not in wild-type cells (Fig. 1a) . In contrast, infection with VSV stimulated similarly high Ifnb mRNA expression in wild-type and Trex1 −/− cells (Fig. 1a) , which suggested that Trex1 did not regulate the type I interferon response to VSV. However, VSV replication was considerably impaired in Trex1 −/− cells relative to its replication in wild-type cells, even though the induction of Ifnb was indistinguishable in the two cell types ( Fig. 1b-d) . Specifically, the abundance of the two main forms of VSV RNA, encoding the glycoprotein G and matrix protein M, in Trex1 −/− cells was 12% and 7%, respectively, that in wild-type cells (Fig. 1b) . We also detected much lower abundance of VSV proteins in Trex1 −/− cells than in wild-type cells after infection with two different doses of VSV (multiplicity of infection (MOI), 2 and 10; Fig. 1c ). VSV titers were also lower in infected Trex1 −/− cells than in wild-type cells (Fig. 1d) . To better quantify and visualize VSV replication, we infected wild-type and Trex1 −/− cells with VSV-P-eGFP, a form of VSV in which enhanced green fluorescent protein (eGFP) is fused to the VSV phosphoprotein P, which is usually associated with foci of viral RNA replication in the cell 21 . We observed less replication of VSV-P-eGFP in Trex1 −/− cells (3.2% GFP) than in wild-type cells (22.2% GFP + ) by flow cytometry (Fig. 1e) . Consistent with those data, analysis of infected wild-type cells by fluorescence microscopy showed bright replication foci marked by P-eGFP, whereas we detected very little green fluorescent signal in VSV-P-eGFP-infected Trex1 −/− cells (Fig. 1f) . We also infected bone marrow-derived macrophages (BMDMs) generated from wild-type, Trex1 +/− and Trex1 −/− mice and found that only Trex1 −/− cells were resistant to infection with VSV ( Fig. 1g,h) .
We next assessed whether the entry of VSV was inhibited in Trex1 −/− cells. This seemed unlikely, as the entry of VSV-Gpseudotyped HIV into Trex1 −/− cells was not impaired 11 , and infection with VSV stimulated indistinguishable expression of Ifnb mRNA in wild-type and Trex1 −/− cells ( Fig. 1a) . Nonetheless, to rule out the possibility of an entry defect, we labeled wild-type VSV virions with the fluorescent dye Dil and monitored the infection of wild-type and Trex1 −/− cells with Dil-labeled VSV by live cell fluorescence microscopy ( Supplementary Fig. 1a ). We observed no difference between wild-type and Trex1 −/− cells in intracellular Dil-labeled VSV at 1 h after infection. We also observed similar amounts of RNA encoding VSV G and M at 1 h after infection in both cell types ( Supplementary Fig. 1b) . These data suggested that VSV replication was blocked at an early stage after entry, such as uncoating or RNA replication, in Trex1 −/− cells. We also found that in contrast to infected wild-type cells, VSV-infected Trex1 −/− cells did not show detectable cytopathic effects ( Supplementary Fig. 2) , consistent with the idea that Trex1 −/− cells were protected against viral infection.
To investigate whether Trex1 was also required for VSV replication in human cells, we studied wild-type skin fibroblasts and Trex1mutant skin fibroblasts (homozygous for the TREX1 mutation that produces the R114H substitution of Trex1; called 'TREX1 R114H/R114H ' here) from a patient with AGS. Arg114 is a critical residue at the interface of the Trex1 dimer, and the R114H substitution substantially disrupts Trex1 function in vitro 22 . R114H represents the most common Trex1 substitution in patients with AGS and has also been associated with SLE 14 . We infected the cells with VSV or VSV-P-eGFP and measured viral RNA. Infection with VSV or VSV-P-eGFP was lower in TREX1 R114H/R114H cells than in wild-type cells, as reflected by the lower abundance of viral RNA and viral proteins and fewer viral replication foci ( Fig. 1i-k) . Given these collective results, we concluded that VSV replication was impaired at an early after entry step in both mouse cells and human cells lacking Trex1 function.
Broad antiviral resistance of Trex1-deficient cells
To determine whether the replication block in Trex1 −/− and TREX1 R114H/R114H cells was unique for VSV, we infected wild-type and Trex1 −/− MEFs and wild-type and TREX1 R114H/R114H human fibroblasts with the following three additional RNA viruses with negativeor postitive-stranded genomes: influenza virus (A/WSN/1933 strain), Sendai virus and West Nile virus (WNV-TX02 strain). We then measured viral RNA and proteins, as well as viral titers in supernatants. None of the three viruses replicated efficiently in Trex1 −/− or TREX1 R114H/R114H cells, in contrast to their replication in wild-type cells (Fig. 2) . These results demonstrated that cells lacking Trex1 function were resistant to infection with several different types of RNA viruses. npg A r t i c l e s Trex1 regulates interferon-independent activation of ISGs Next we investigated the mechanism of antiviral resistance in Trex1 −/− cells. We first examined gene-expression profiles by infecting wildtype and Trex1 −/− MEFs with VSV, influenza virus, Sendai virus or West Nile virus, or mock infecting the cells, followed by isolation of total RNA and analysis by high-throughput sequencing technologies (RNA-Seq) that offer quantitative measurement of both host and viral RNA simultaneously (Fig. 3a) . The changes in gene expression confirmed by quantitative PCR were similar to those obtained by RNA-Seq ( Fig. 3b, Supplementary Figs. 3 and 4 and data not shown), which emphasized the quantitative power of our RNA-Seq analysis. We first analyzed the gene-expression profiles of uninfected wild-type and Trex1 −/− samples with Ingenuity pathway-analysis software and found that the gene network most represented in Trex1 −/− cells relative to its representation in wild-type cells was the network of 'antimicrobial response, inflammatory response, infectious diseases' , which consists mostly of ISGs ( Supplementary Fig. 5a,b) . The networks of 'interferon signaling' and 'cytosolic pattern-recognition receptors' were also 
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A r t i c l e s among the top-ranked canonical pathways with high 'hit ratio' (determined by the frequency of genes in a pathway that are represented in a data set; Supplementary Fig. 5c ). We then constructed a heat map of genes involved in the 'antimicrobial response' network and representative genes from each virus based on the expression values (and standard deviation (s.d.)) of each gene across all samples ( Fig. 3a) .
All four RNA viruses replicated less efficiently in Trex1 −/− cells than in wild-type cells ( Fig. 3a and Supplementary Fig. 4) , with values ranging from 4% to 22% of those observed in wild-type cells. We also found that many ISGs, such as Ifit1, Ifit3, Isg15, Zbp1 and Usp18, showed considerable induction in uninfected Trex1 −/− cells ( Fig. 3b and Supplementary Fig. 3) . Notably, uninfected Trex1 −/− cells had an ISG-activation signature that resembled that of infected wild-type cells ( Supplementary Fig. 6 ), which suggested that the lack of Trex1 function alone was sufficient to initiate an antiviral state. The establishment of this antiviral state seemed to be independent of interferon, because we did not detect any activation of interferon-encoding genes or interferon proteins ( Fig. 3c and Supplementary Fig. 3) . Moreover, the patterns of induction of Ifnb1 by various viruses were indistinguishable in wild-type and Trex1 −/− cells ( Fig. 3d ; influenza virus is known to inhibit the activation of interferon 23 ). In contrast, the abundance of Ifit1 mRNA was low in wild-type cells and increased after viral infection, whereas Trex1 −/− cells began with high expression of Ifit1 (that seemed to be equivalent to that observed in infected wild-type cells), and it remained high after viral infection ( Fig. 3e) . Trex1 −/− cells treated with increasing doses of recombinant IFN-β showed a further increase in Ifit1 expression ( Supplementary Fig. 7) , which suggested that Trex1 −/− cells were able to respond to interferon signaling. ISGs with substantial induction by Trex1 deficiency, such as those encoding members of the IFIT family, encode molecules with intrinsic antiviral activity against RNA viruses 24, 25 . Of note, not all known ISGs were activated in Trex1 −/− cells; those encoding members Iftnb1 mRNA (fold)
Irf7 mRNA (fold) npg of the IFITM family had similar expression in wild-type and Trex1 −/− cells (Supplementary Fig. 3 ). Together our data suggested substantial activation of a subset of ISGs in Trex1 −/− cells independently of the interferon response.
To further confirm that the activation of ISGs was specific to the loss of Trex1 function, we knocked down Trex1 expression in wild-type MEFs through the use of three different small interfering RNA (siRNA) constructs and noted significantly higher expression of Ifit1, Ifit3 and Irf7 (also an ISG), but not of Ifitm3, Ifna4 or Ifnb1 (Fig. 3f) . We also knocked down Trex1 expression in MEFs deficient in the receptor for IFN-α and IFN-β (Ifnar1 −/− MEFs) and observed similarly higher expression of Ifit1 and Irf7 (Fig. 3g) , which further suggested that the activation of ISGs regulated by Trex1 was interferon independent. To determine whether the activation of ISGs or the interferon pathway contributed to the control of viral infection in Trex1 −/− cells, we transfected wild-type and Trex1 −/− cells with a control siRNA or siRNA specific for the products of two ISGs (IFIT1 and IFITM3) or two key components of the interferon signaling pathway (STAT1 and STAT2). We then infected cells with VSV-P-eGFP and measured infectivity by flow cytometry (Fig. 3h ). Knockdown of IFIT1 or IFITM3 in Trex1 −/− cells partially alleviated the blockade of VSV replication, consistent with the known antiviral functions of these two moleules [24] [25] [26] . In contrast, knockdown of STAT1 or STAT2 had no effect on VSV replication, which further demonstrated that the interferon response was not required for the control of viral infection in Trex1 −/− cells. To determine whether this ISG-induction signature was present in primary cells of the immune response and tissues from Trex1 −/− mice, we isolated total RNA from whole spleen, heart and BMDMs from wild-type, Trex1 +/− and Trex1 −/− mice and measured Ifit1, Irf7 and Ifnb mRNA. We observed an induction of ISGs of up to 30-fold in whole tissues and up to 60-fold in primary cells of the immune system only in Trex1 −/− mice, relative to their expression in wild-type mice (Fig. 3i) . We also observed very low Ifnb expression in all samples from Trex1 −/− mice ( Fig. 3i) , consistent with published reports showing restriction of interferon expression to a subset of heart-muscle cells 12, 19 .
We also used RNA-Seq to analyze total RNA from uninfected wild-type fibroblasts or fibroblasts from patients with AGS with the TREX1 R114H/R114H mutation or other mutations linked to AGS, including the RNASEH2C D39Y/D115fs and SAMHD1 R290H/Q548X mutations 27 . We again found substantial upregulation of a subset of ISGs, but not interferon-encoding genes, in TREX1 R114H/R114H cells (Fig. 4a) . Notably, the ISG-activation signature was weak in RNASEH2C D39Y/D115fs cells and was not present in SAMHD1 R290H/Q548X cells (Fig. 4a) . To determine whether the same group of ISGs was activated in Trex1 −/− and TREX1 R114H/R114H cells, we selected 35 ISGs that are expressed in both mouse and human cells and compared their induction in Trex1 −/− and TREX1 R114H/R114H cells. ISGs that were induced in Trex1 −/− MEFs were also induced in TREX1 R114H/R114H fibroblasts, with a correlation r 2 value of 0.49 (Fig. 4b) . We observed weak correlation between gene induction in Trex1 −/− cells and that in RNASEH2C D39Y/D115fs cells (r 2 = 0.14) and no correlation for that in Trex1 −/− cells and SAMHD1 R290H/Q548X cells (r 2 = 0.04). Our data demonstrated that Trex1 also regulated the activation of ISGs in human fibroblasts.
Factors for interferon-independent ISG activation
We next sought to identify factors of the innate immune system required for the interferon-independent activation of ISGs in Trex1deficient cells. We chose to measure Ifit1 mRNA as an example of a Trex1-regulated ISGs because Ifit1 was the gene upregulated the most in Trex1 deficiency. We first examined the effect of IRF3, which activates ISGs directly 9, 28 . We measured Ifit1 mRNA in wild-type, Trex1 −/− and Trex1 −/− Irf3 −/− MEFs and found induction of Ifit1 in Trex1 −/− single-deficiency cells and that the induction was inhibited by Trex1 −/− Irf3 −/− double deficiency (Fig. 5a) , which suggested that IRF3 was required for activation of Ifit1. To determine whether IRF3 was also required for antiviral activity in the setting of Trex1 deficiency, we infected wild-type, Trex1 −/− and Trex1 −/− Irf3 −/− MEFs with VSV or Sendai virus and measured viral proteins by immunoblot analysis or flow cytometry ( Fig. 5b-d) . Infection with VSV or Sendai virus was inhibited in Trex1 −/− cells, and infection with each was restored to close to wild-type amounts in Trex1 −/− Irf3 −/− cells. Therefore, IRF3 was a key component of the antiviral resistance in Trex1 −/− cells.
We next explored which innate immune pathway upstream of IRF3 was involved in the activation of ISGs in Trex1 −/− cells. IRF3 is activated mainly by cytosolic DNA-or RNA-sensing pathways mediated by STING-TBK1 or RIG-I-MAVS, respectively. Therefore, we knocked down key components of each pathway in Trex1 −/− cells through the use of siRNA and measured Ifit1 expression. Knockdown 
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A r t i c l e s of IRF3, IRF7, TBK1, STING or IFI204 resulted in significantly lower Ifit1 expression, whereas knockdown of RIG-I or MAVS had no effect (Fig. 5e) . We also did not observe any effect on Ifit1 expression in Trex1 −/− cells after knocking down TLR7 or TLR9 (data not shown). Knockdown of IRF3, IRF7 or TBK1 also diminished the VSV-replication block in Trex1 −/− cells (Fig. 5f) . These results suggested that the cytosolic DNA-sensing machinery was required for the interferon-independent activation of ISGs in Trex1-deficient cells, but the cytosolic RNA-sensing machinery was not. Knockdown of STING did not seem to enhance VSV replication in Trex1 −/− cells, probably because the VSV-replication assay measures the entire life cycle of VSV, and many host factors may contribute to this, or because STING also regulates many other genes 8 encoding molecules that could be required for VSV replication. The same cytosolic DNA-sensing pathway is also involved in the activation of interferon-encoding genes during viral infection 2,11 , whose products can then activate ISGs. Therefore, we did double knockdown of Trex1 plus components of the cytosolic DNA-sensing pathway in Ifnar1 −/− MEFs. Ifit1 expression was higher after knockdown of Trex1, and that was diminished by further knockdown of TBK1, IRF7 or STING (Fig. 5g) . Knockdown of Trex1 in Ifnar1 −/− MEFs also inhibited VSV replication, and further knockdown of TBK1 or IRF7 alleviated that inhibition (Fig. 5h) . Together our data suggested that the core cytosolic DNA-sensing machinery (STING-TBK1-IRF3-IRF7) was involved in activating ISGs directly in cells with diminished or no Trex1 activity.
Trex1 regulates lysosomal biogenesis via TFEB and mTORC1
We next sought to identify the underlying basis for the activation of ISGs in Trex1 −/− and TREX1 R114H/R114H cells. We first considered the possibility that Trex1 directly inhibits the cytosolic DNA-sensing machinery. To test this, we used 293T human embryonic kidney cells, in which the overexpression of STING induced sixfold more Ifit1 mRNA (Supplementary Fig. 8 ). We then coexpressed STING and increasing amounts of Trex1 to determine whether overexpression of Trex1 would inhibit the STING-mediated activation of Ifit1.
We did not observe any effect on ifit1 induction after overexpression of Trex1 (Supplementary Fig. 8) . The same degree of Trex1 overexpression inhibits the HIV-mediated activation of interferon-encoding genes 11 . These results suggested that Trex1 did not directly inhibit the cytosolic DNA-sensing machinery.
We then hypothesized that perhaps the accumulation of self ligands or a cellular abnormality in Trex1 −/− or TREX1 R114H/R114H cells might be detected by the STING-TBK1-IRF3-IRF7 pathway. We first assessed the abundance and morphology of cellular organelles in wild-type and Trex1 −/− cells by immunofluorescence staining of well-defined organelle markers (Fig. 6a) . We did not observe substantial differences between those cells in their mitochondria, Golgi apparatus, endoplasmic reticulum or early endosomes. However, late endosomes (identified by staining with antibody to LAMP-1) and lysosomes (identified by staining with the probe LysoTracker Red) seemed to be more abundant in Trex1 −/− cells than in wildtype cells (Fig. 6a) . We also observed a similarly greater abundance of the late endosome-lysosome compartment in Trex1 −/− BMDMs than in wild-type or Trex1 +/− BMDMs (Fig. 6b) . To determine if this difference was also present in human cells, we stained wildtype and TREX1 R114H/R114H human fibroblasts, as well as control HeLa human cervical cancer cells and HeLa cells in which Trex1 was knocked down (by siRNA), with LysoTracker Red. In both cases, we observed much more LysoTracker Red staining of Trex1-deficient cells than of wild-type cells ( Fig. 6c and Supplementary Fig. 9 ), which indicated expansion of the late endosome-lysosome compartment in cells that lacked Trex1 function. We quantified the lysosomal expansion by flow cytometry of live cells with LysoTracker Red and found that Trex1 −/− cells and TREX1 R114H/R114H cells had three-to fivefold more lysosomes than did wild-type cells (Fig. 6d) . We also detected more of the lysosomal membrane proteins LAMP-1 and NPC1 in TREX1 R114H/R114H cells and Trex1 −/− cells than in wild-type cells by immunoblot analysis (Fig. 6e) , which suggested enhanced lysosomal biogenesis in Trex1-deficient cells. To further confirm the expansion of the lysosome compartment, we analyzed wild-type and 
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A r t i c l e s Trex1 −/− cells by electron microscopy. Trex1 −/− cells had significantly more lysosome vacuolar structures ( Fig. 6f,g) . Those structures were surrounded by single-layer membranes, some of which contained electron-dense cellular materials commonly found in lysosomes (Fig. 6f, inset) . Lysosomes are important organelles for the breakdown and turnover of other cellular organelles (such as mitochondria), proteins and nucleic acids 29 . Of note, we did not observe excessive accumulation of undigested cellular materials in these lysosomes; such accumulation is often found in cells associated with lysosomal storage diseases 30 . We also did not detect more autolysosomes in Trex1 −/− cells than in wild-type cells, as measured by electron microscopy, the formation of dots of GFP-tagged autophagy marker LC3, and immunoblot analysis of p62, a ubiquitin-binding scaffold protein, and LC3 ( Supplementary Fig. 10 and data not shown).
To determine whether the lysosome-expansion phenotype in Trex1 −/− cells was caused by the induction of genes encoding proteins of the lysosome, we measured the expression of Ctsa, Sgsh, Lamp1, Mcoln1 and Tpp1, which encode enzymes or structural proteins of the lysosome. All five genes were upregulated three-to fivefold in Trex1 −/− cells relative to their expression in wild-type cells, whereas other nonlysosomal genes were not (Fig. 7a) . Many other genes encoding molecules involved in lysosomal biogenesis were also upregulated in Trex1 −/− cells relative to their expression in wild-type cells (Supplementary Fig. 11 ). Lysosomal genes are regulated by TFEB through the recognition of conserved binding sites in their promoters.
TFEB is a master regulator of the 'CLEAR' gene network ('coordinated lysosomal expression and regulation') 31 , and overexpression of TFEB results in higher lysosomal gene expression and promotes lysosome expansion 32 . TFEB resides mostly in the cytoplasm and translocates to the nucleus after complex post-translational modifications 33, 34 . We did not observe any difference between wild-type and Trex1 −/− cells in their abundance of Tfeb mRNA or TFEB protein ( Fig. 7a and data not  shown) . To examine the subcellular localization of TFEB, we stained wild-type and Trex1 −/− cells with an antibody to TFEB and found that endogenous TFEB became mostly nuclear in Trex1 −/− cells (Fig. 7b) . This result suggested that the higher lysosomal gene expression and expansion of the lysosomal compartment were connected to altered localization of TFEB in Trex1 −/− cells. We did not detect any interaction between Trex1 and TFEB by immunoprecipitation of proteins from wild-type MEFs (data not shown), which suggested that Trex1 did not regulate the translocation of TFEB through direct binding and retention in the cytosol.
To determine whether TFEB function was required for the activation of ISGs and antiviral activity of Trex1 −/− cells, we knocked down TFEB expression in Trex1 −/− cells and measured Ifit1 and Ifit3 mRNA in uninfected cells, as well as VSV replication in those same cells. Knockdown of TFEB in Trex1 −/− cells resulted in lower expression of both Ifit1 and Ifit3 and more VSV replication ( Fig. 7c-e ). Knockdown of TFEB in wild-type MEFs did not affect Ifit1 or other genes encoding molecules of the innate immune system predicted to be targets 
A r t i c l e s of TFEB 31 (Supplementary Fig. 12 ), which suggested that TFEB did not regulate ISGs directly. Moreover, we found that Trex1 −/− Irf3 −/− cells had higher expression of lysosomal genes and LAMP-1 protein, similar to that in Trex1 −/− cells, whereas ISG expression was much lower in Trex1 −/− Irf3 −/− cells than in Trex1 −/− cells ( Supplementary  Fig. 11 ), which suggested that lysosomal biogenesis (regulated by TFEB) acted upstream of ISG expression (regulated by IRF3 and IRF7). Overexpression of TFEB promotes lysosomal biogenesis 32 . To determine whether manipulating the expression or nuclear translocation of TFEB in wild-type cells also induced the expression of ISGs, we overexpressed TFEB in wild-type MEFs and found that Ifit1 expression was increased in a dose-dependent manner (Fig. 7f) . We also treated wild-type MEFs with chloroquine, which induces translocation of TFEB to the nucleus 35 , and observed a dose-dependent increase in the expression of Mcoln1 (a lysosomal gene) and Ifit1 (Fig. 7g) . These data further supported the proposal of a link between TFEB function in lysosomal biogenesis and induction of ISGs. Of note, the treatment of Trex1 −/− cells with chloroquine did not restore VSV replication (Supplementary Fig. 13 ), probably because of the known antiviral effect of chloroquine [36] [37] [38] .
One of the upstream regulators of the translocation of TFEB to the nucleus is mTORC1, and inhibition of mTORC1 activity under many conditions promotes the transport of TFEB into the nucleus 35, 39 .
We thus examined mTORC1 activity in infected and uninfected wild-type and Trex1 −/− cells. We found that infection with VSV induced mTORC1 activity in wild-type MEFs (Fig. 7h) , consistent with the function of mTORC1 as a proviral factor 40 . The activity of mTORC1 was much lower in uninfected and infected Trex1 −/− cells than in uninfected and infected wild-type cells (as assessed by phosphorylation of the kinase S6K, the ribosomal protein S6P and the translationinitiation inhibitor 4E-BP1; Fig. 7h,i) . We also found that knockdown of mTOR (via two independent siRNA molecules) in wild-type MEFs resulted in higher Ifit1 expression ( Fig. 7j) . Moreover, expression of Flag-tagged Trex1 enhanced mTORC1 activity in wild-type cells and restored mTORC1 activity in Trex1 −/− cells relative to the activity achieved with the vector plasmid control (Fig. 7k) . Our data suggested that Trex1 was important for maintaining mTORC1 activity and that a lower abundance of mTOR led to the induction of ISGs. Consistent with our data, lower mTORC1 activity has been associated with antiviral effects 40 . Collectively, our data suggested that Trex1 regulated lysosomal biogenesis through TFEB and mTORC1 and that lysosomal biogenesis had a critical role in innate immunity and antiviral defense (Supplementary Fig. 14) .
DISCUSSION
It is well established that interferon has an important role in antiviral immunity. Cells are equipped with an extensive network of sensing mechanisms in the innate immune system for the detection of invading pathogens through recognition by pattern-recognition receptors. When such receptors are engaged, they trigger signaling pathways that often lead to the activation of interferon expression 3 . Infection with enveloped viruses also triggers an interferon-independent pathway that involves the direct activation by IRF3 of a subset of ISGs 28 . In fact, IRF3 can bind to the promoters of many ISGs in addition to those of interferon-encoding genes 41 . The promoters of interferonencoding genes (such as Ifnb1) are complex, containing both positive and negative regulatory elements for transcripion factors such as members of the IRF family, NF-κB and AP-1, and a concerted effort by multiple transcription factors is often required for their stimulation. In contrast, the promoters of many ISGs (such as Ifit1) are simpler and can be easily turned on by IRF proteins independently of interferon 9, 41 . Direct activation of antiviral genes is important for 'nonprofessional' interferon-producing cells such as fibroblasts to effectively defend themselves against viral infection or for cells to defend themselves against viruses that have evolved mechanisms to disrupt the interferon response. It is also advantageous for cells to rapidly induce some ISGs after viral infection before a stronger and more sustained response can be established by interferon signaling pathways. A study of a cytosolic RNA-sensing pathway has provided evidence that interferon-independent activation of ISGs mediated by peroxisomal MAVS is functionally important for defense against infection with RNA viruses 10 . Very little is known about whether interferon-independent activation of ISGs occurs in the absence of infection and how it is regulated. Here we have identified Trex1, a cytosolic protein associated with the endoplasmic reticulum, as a key negative regulator of interferonindependent activation of Ifit1 and other ISGs in uninfected cells. When the function of Trex1 was disrupted, either by genetic deficiency in mice or by a homozygous mutation in humans, or by siRNAmediated knockdown in a variety of cell types, a subset of ISGs were activated independently of interferon, which led to an antiviral state. Notably, the induction of ISGs in Trex1-deficient cells was sustained at a very high degree and achieved an antiviral state similar to that caused by the interferon-dependent pathway. That was in contrast to the interferon-independent response induced by viral infection in wild-type cells that seems to be temporary and less robust 10 . We also challenged wild-type and Trex1 −/− mouse cells and TREX1 R114H/R114H human cells with a variety of RNA viruses, including VSV, influenza virus, Sendai virus and West Nile virus, and all these viruses failed to replicate in cells that lacked Trex1 function.
We have also identified a pathway in the innate immune system, involving STING, TBK1, IRF3 and IRF7, that was important for the interferon-independent activation of ISGs in Trex1-deficient cells. STING is a critical factor for the sensing of pathogen-associated DNA or cyclic di-GMP in the cytosol and subsequent induction of interferon expression 2,7 . Our data have expanded the function of the STING-TBK1-IRF3-IRF7 pathway to include both interferon-dependent and interferon-independent branches as downstream pathways. A published study has also shown that STING activates the phosphorylation of STAT6 after viral infection, which then induces the expression of chemokines such as CCL2, CCL20 and CCL26 and homing of cells of the immune system 8 . We did not observe induction of the expression of those chemokines in Trex1 −/− or TREX1 R114H/R114H cells relative to their expression in wild-type cells (data not shown). Collectively, our study has expanded the understanding of STING and associated factors of the innate immune system as a versatile machinery that can activate multiple distinct downstream pathways.
Our data have also shed some light on the potential endogenous trigger of interferon-independent activation of ISGs. We found that Trex1-deficient or Trex1-mutant cells had excessive amounts of lysosomal vacuoles and expanded lysosomal compartments, as determined by immunofluorescence and immunoblot analysis of lysosomal markers, quantitative RT-PCR analysis of lysosomal genes, and electron microscopy. Consistent with such enhanced lysosome biogenesis, the master regulator of lysosome genes TFEB translocated to become predominantly nuclear in Trex1 −/− cells. We also found lower mTORC1 activity in Trex1 −/− cells and restoration of mTORC1 activity after expression of Flag-tagged Trex1 in Trex1 −/− cells; this suggested an important role for Trex1 in maintaining the activity of mTORC1, which regulates the translocation of TFEB to the nucleus 35, 39 . We also provided the following lines of evidence that demonstrated a functional linkage of TFEB-regulated lysosomal biogenesis to the activation of ISGs: knockdown of TFEB in Trex1deficient cells tempered the activation of ISGs and antiviral immunity; overexpression of TFEB in wild-type cells, which promotes lysosomal biogenesis 32 , resulted in higher Ifit1 expression; treatment of wildtype cells with chloroquine, which induces translocation of TFEB to the nucleus 35 and has antiviral activity [36] [37] [38] , resulted in higher Ifit1 expression, up to 15-fold; and knockdown of mTOR by siRNA in wild-type cells also resulted in higher Ifit1 expression. Furthermore, given our observation of higher expression of lysosomal genes and a greater abundance of lysosomal proteins and lack of excess accumulation of undigested contents, Trex1 −/− cells probably have enhanced lysosomal function. The release of abnormally large amounts of processed peptides or nucleic acids into the cytosol or into the extracellular space (via exocytosis 42 ) might break cellular homeostasis or immunotolerance or exceed the threshold for cytosolic sensing of DNA. The exact identity of such cytosolic DNA remains unclear; published studies have indicated that it might be DNA-replication debris 20 or endogenous retroelements 19 . Aberrant functions of lysosomes have been indicated in lupus nephritis, in which lysosomal contents mimic viral particles and activate innate immunity 43 . It is also possible that a greater abundance of lysosome vacuoles could result in a membrane perturbation that would elicit an interferon-dependent or interferon-independent antiviral response 9, 44 . Further studies are needed to distinguish among these possibilities. Collectively, our work has demonstrated a link between lysosomal biogenesis and activation of ISGs by the innate immune system, as well as a previously unknown role for Trex1 in regulating lysosomal biogenesis through TFEB and mTORC1.
Trex1 inhibits HIV-mediated activation of interferons 11 . Here we confirmed that finding and further identified a previously unknown function of Trex1 in the regulation of interferon-independent activation of the innate immune response through lysosomal biogenesis in uninfected cells, which resulted in a broad-spectrum antiviral state in which the replication of several different RNA viruses was inhibited. Both functions of Trex1 shared a similar signaling pathway of the innate immune system that involved STING-TBK1-IRF3, which was able to activate multiple downstream pathways. The upstream stimulus for HIV-mediated interferon activation is HIV DNA from nonproductive reverse transcription 11 , whereas the upstream stimulus for the interferon-independent pathway probably involves lysosome function.
Our work has also provided further insight into pathogenetic mechanisms underlying systemic autoimmunity associated with TREX1 mutation, such as SLE, a prototypical autoimmune disease. Central to SLE pathogenesis is that ineffective waste disposal due to impaired apoptosis or defective clearance of cellular debris leads to npg A r t i c l e s excessive release of autoantigens, which activate sensors of the innate immune system and trigger immunological responses that lead to the formation of autoantibodies 45 . Our findings have identified a previously unknown cell-intrinsic mechanism for the initiation of autoimmunity due to enhanced lysosome function. Moreover, the constitutive type I interferon-independent 'ISG-signature' detectable in a variety of cell types and tissues may potentially represent a valuable biomarker that could be applied as a measure of clinical outcome.
In summary, our study has idenitfied a signaling cascade that involved the biogenesis of a cellular organelle (the lysosome) and cytosolic detection by the innate immune system. Both segments of the cascade functioned together to establish an antiviral state in Trex1-deficient cells independently of interferon activation or viral infection. We have identified many components of this cascade, some of which (TFEB and mTORC1) have not been directly linked to intrinsic antiviral immunity before, to our knowledge. We have also identified previously unknown functions for known regulators of the innate immune system, such as Trex1 and STING. Further understanding of the mechanism by which this signaling cascade is regulated will have implications for the understanding of not only antiviral defense but also the pathogenic mechanisms that underlie autoimmune diseases.
METHODS
Methods and any associated references are available in the online version of the paper.
